madman
Super Moderator
* He says the healthy-volunteer trials showed sexual side effects in close to 90% of people while the marketed figure was under 5%, and he explains why he considers the word "antidepressant" itself a marketing term.
35:33 GLP-1s and the Hims cascade: the same playbook
Dr. David Healy, psychiatrist, psychopharmacologist, and author of Pharmageddon, returns to lay out what he argues the drug companies concealed about antidepressants. He says the healthy-volunteer trials showed sexual side effects in close to 90% of people while the marketed figure was under 5%, and he explains why he considers the word "antidepressant" itself a marketing term. Host Mike Vera, MS, NBC-HWC, walks through the trial data, informed consent, and whether the same pattern is now repeating with GLP-1 drugs. This is a discussion of Dr. Healy's research and perspective, shared for educational purposes only, and it is not medical advice.
TIMESTAMPS
0:00 Cold open
0:37 Who is Dr. David Healy (and a content note)
3:15 The PSSD congress: patients doing the science
5:00 Goldstein's scans: the damage is real, and reversible
8:00 Beyond sex: muscle, balance, and a young athlete
12:35 Is this chemical castration? "Don't ask about sex" and the 90% they hid
16:24 "Antidepressant" is a marketing term (only 1 in 6 benefit)
18:00 The toxic dose: how Prozac cleared the FDA
22:44 RFK Jr., pulling SSRIs, and the withdrawal danger
25:44 "No side effects": the under-oath claim and the statistics trick
27:58 The elderly trapped on SSRIs, and the "perky physio"
35:33 GLP-1s and the Hims cascade: the same playbook
39:19 Media, the Lexapro meme, and a worse-off generation
44:00 Introverts, ASD, and the euthanasia craze
47:44 Eugenics, Mangione, and is anyone doing it right?
50:24 Ending on hope, and where to find Dr. Healy
35:33 GLP-1s and the Hims cascade: the same playbook
Dr. David Healy, psychiatrist, psychopharmacologist, and author of Pharmageddon, returns to lay out what he argues the drug companies concealed about antidepressants. He says the healthy-volunteer trials showed sexual side effects in close to 90% of people while the marketed figure was under 5%, and he explains why he considers the word "antidepressant" itself a marketing term. Host Mike Vera, MS, NBC-HWC, walks through the trial data, informed consent, and whether the same pattern is now repeating with GLP-1 drugs. This is a discussion of Dr. Healy's research and perspective, shared for educational purposes only, and it is not medical advice.
TIMESTAMPS
0:00 Cold open
0:37 Who is Dr. David Healy (and a content note)
3:15 The PSSD congress: patients doing the science
5:00 Goldstein's scans: the damage is real, and reversible
8:00 Beyond sex: muscle, balance, and a young athlete
12:35 Is this chemical castration? "Don't ask about sex" and the 90% they hid
16:24 "Antidepressant" is a marketing term (only 1 in 6 benefit)
18:00 The toxic dose: how Prozac cleared the FDA
22:44 RFK Jr., pulling SSRIs, and the withdrawal danger
25:44 "No side effects": the under-oath claim and the statistics trick
27:58 The elderly trapped on SSRIs, and the "perky physio"
35:33 GLP-1s and the Hims cascade: the same playbook
39:19 Media, the Lexapro meme, and a worse-off generation
44:00 Introverts, ASD, and the euthanasia craze
47:44 Eugenics, Mangione, and is anyone doing it right?
50:24 Ending on hope, and where to find Dr. Healy
